Open main menu
Home
Random
Donate
Recent changes
Special pages
Community portal
Preferences
About Stockhub
Disclaimers
Search
User menu
Talk
Contributions
Create account
Log in
Editing
HealthMe
(section)
Warning:
You are not logged in. Your IP address will be publicly visible if you make any edits. If you
log in
or
create an account
, your edits will be attributed to your username, along with other benefits.
Anti-spam check. Do
not
fill this in!
==Investment Interview== '''Explain what your venture does.''' HealthMe is tackling the burden of medical documentation by developing a NLP-powered mobile application that automatically generates medical reports for doctors in real-time. '''What stage is your business?''' Prototype. '''Describe your advisers.''' Martin Rennison, Martin Carpenter, Prof James Henderson. '''Give an overview of your startup's financing history.''' We have invested £70k of our own money. '''Explain the ownership structure of your company.''' HealthMe 3 founders hold 100% of the shares. '''How many employees do you have?''' HealthMe is a UK SME with a core-team of Dr Mohamed Alibashe, Loy Lobo, Aditya Hadiputra and Yu Guan. The core team have previously worked together on successful projects (customer discovery and validation, proof-of-concept and product-market-fit works) and are able/setup to work remotely. Dr Mohamed Alibashe, co-founder and CEO: FTE. Yu Guan, co-founder and CTO: part-time, will work FT after funding. Loy Lobo, co-founder and Head of Business Development: part-time. Aditya Hadiputra, Head of Finance: part-time. Huizi Zhang, Lead UX/UI: part-time Sidhant Kumar, NLP Engineer: part-time. NLU engineer, FTE: with the investment. '''How much money are you seeking to raise in the current round?''' £250-400k. '''Do you have any existing commitments to the current round?''' £105k is committed. '''Explain why you are raising finance.''' We are raising finance for 3 reasons: 1) finalise our product development 2) launch 3 trials 3) acquire 1-2 initial customer(s). '''Please explain the history of your venture.''' During my clinical activity as a digestive surgeon at the Geneva University Hospital, I experienced the burden of medical documentation. I used to work overtime to complete and finalize patients notes. I decided to tackle that problem and came at Imperial College to study for my MBA and work on this business idea. I met the rest of the team at Imperial, build our network and received the support from the business school and the Enterprise Lab. We did our customer discovery and design thinking at Imperial College NHS trust. '''Please explain the longer term, future vision for the Company''' The long term objective is to build the next generation of medical record system, that captures the value of speech to empower not only clinicians but also patients. '''Explain the core technologies and/or service propositions of your venture.''' HealthMe's app will transcribe the medical consultation between a doctor and patient and generate a medical report at the end of the meeting or appointment. The primary innovation will be to create the first solution that automatically generates medical reports for doctors in real time with AI. HealthMe's app will generate the AI data source during the consultation through speech-to-text. Then, HealthMe's algorithms will retrieve medical information and categorise them into topics and diagnoses, which will be used for the creation of the medical reports. This innovative mobile application will automate the process of medical documentation and data entry in the electronic medical record system. '''Does your commercial strategy rely on intellectual property assets?''' HealthMe has identified a patentable step in a unique process and is working actively to protect it. However our commercial strategy doesn't rely only on the IP. The real value will come from solving this significant unmet global need for doctors. '''What commercial progress have you made?''' We were accepted into different prestigious accelerator programs: Imperial College accelerator program, Oxford Panaceas Stars, SimDH, Barclay’s P4 Precision Medicine -We developed the algorithms for our core technology, reaching an accuracy of 96% -We built a functioning prototype (TRL 5) that is in beta test phase -We developed the designs of our interfaces (patient and doctor), based on our end-users insights -We established a network of 3 NHS trusts which will provide test beds for the pilots. -We received LOI to buy our solution from 3 NHS trusts and one of the UK biggest homecare provider group. We also received intents to purchase our solution from a couple of GP practices and more importantly from one of the UK biggest chain of private clinics. -We also received interest from a publicly traded company to join forces.
Summary:
Please note that all contributions to Stockhub may be edited, altered, or removed by other contributors. If you do not want your writing to be edited mercilessly, then do not submit it here.
You are also promising us that you wrote this yourself, or copied it from a public domain or similar free resource (see
Stockhub:Copyrights
for details).
Do not submit copyrighted work without permission!
Cancel
Editing help
(opens in new window)